Clinical and Metabolic Characterization of Bronco-Pulmonary Carcinoma in Surgical Stadium
Bronchial-Pulmonary carcinomas (BPC) present in advanced stages in nearly 70% of cases. Clinical and pathological criteria have to be strict to fulfil personalized therapy and direct molecular pathology. The 18F-Flourodeoxiglucose (FDG) uptake integrates clinical diagnosis and we hypothesized that F...
Saved in:
Main Author: | |
---|---|
Format: | Dissertation |
Language: | English |
Published: |
ProQuest Dissertations & Theses
01-01-2012
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Bronchial-Pulmonary carcinomas (BPC) present in advanced stages in nearly 70% of cases. Clinical and pathological criteria have to be strict to fulfil personalized therapy and direct molecular pathology. The 18F-Flourodeoxiglucose (FDG) uptake integrates clinical diagnosis and we hypothesized that FDG uptake together with CK7, CK5.6/p63, TTF1, CD56, Vimentin expression and mitochondrial DNA (mtDNA) content define criteria to stratify lung cancer in small biopsies.A series of 40 surgical specimens whose patients had preoperative Positron Emission Tomography/Computed Tomography (PET/CT) was introduced in this study by recurring to archive tissue to submit to immunohistochemistry (IHC) and mtDNA validation.WHO 2004 and IASLC/ATS/ERS 2011 proposal classifications were applied to correlate with the previous parameters.TTF1 Positive adenocarcinomas had lower 18F-FDG uptake (p=0,006) compared with TTF1 negative adenocarcinomas and these equal epidermoid carcinomas (p=0,396). Here called complex group of the other histological types have 18F-FDG uptake intermingled with the other types needed reliable IHC to subclassification; mtDNA correlated with 18F-FDG uptake (p=0.0059).As an approach to subclassify BPC in small biopsies, 18F-FDG uptake together with IHC defined panel will allow stratification for personalized therapy and clinical follow up: epidermoid carcinoma, bronchial adenocarcinoma, TRU adenocarcinoma, adenosquamous |
---|---|
ISBN: | 9798819346327 |